N/A
N=3
Robotic Single Port Donor Nephrectomy
Renal Transplant Donor of Left Kidney · Donor Nephrectomy · Robotic Surgery · Single-port
Bottom Line
View on ClinicalTrials.gov: NCT01925677 ↗Enrolled (actual)
3
Serious AEs
0.0%
Results posted
Nov 2019
Primary outcome: Primary: Successful Completion of the Surgical Procedure — 3 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- da Vinci® Single-Site™ (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Maryland, Baltimore
- Primary completion
- Aug 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Successful Completion of the Surgical Procedure |
3 | — |
| SECONDARY Operative Times |
82 | — |
| SECONDARY Blood Loss |
77 | — |
| SECONDARY The Comparison of Surgeon Ergonomic Questionnaires in Robotic Assisted Versus Standard Laparoscopic Single Port Donor Nephrectomies. |
3 | — |
Summary
Feasibility study on robotic-assisted single-site donor nephrectomy utilizing da Vinci instrumentation and Single-Site platforms.
Eligibility Criteria
Inclusion Criteria
- Patient must be approved by the Living Donor Center.
- Patient must have compatible blood type with the recipient.
- Patient must have body mass index less than 35.
- Patient must have appropriate anatomy for left kidney donation.
Exclusion Criteria
- Any patient receiving anticoagulant drugs such as Coumadin or warfin
- Any patient suffering from an active urinary tract infections
- Any patients suffering from cancer.
- Any patients suffering from diabetes.
- Any patients suffering from kidney disease.
- Any patients suffering from heart disease.
- Any patients suffering from liver disease.
- Any patients suffering from HIV or hepatitis
- Any patients suffering from previous major abdominal surgery.
- Any patients suffering from more than two left renal arteries.
Data sourced from ClinicalTrials.gov (NCT01925677). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.